Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Adverse drug reaction reporting via mobile applications: A narrative review (CROSBI ID 316103)

Prilog u časopisu | pregledni rad (znanstveni) | međunarodna recenzija

Leskur, Dario ; Bozić, Joško ; Rušic, Doris ; Perišin, Ana Šešelja ; Cohadžić, Tin ; Pranić, Shelly ; Modun, Darko ; Bukić, Josipa Adverse drug reaction reporting via mobile applications: A narrative review // International journal of medical informatics, 168 (2022), 104895, 7. doi: 10.1016/j.ijmedinf.2022.104895

Podaci o odgovornosti

Leskur, Dario ; Bozić, Joško ; Rušic, Doris ; Perišin, Ana Šešelja ; Cohadžić, Tin ; Pranić, Shelly ; Modun, Darko ; Bukić, Josipa

engleski

Adverse drug reaction reporting via mobile applications: A narrative review

Introduction: Pharmacovigilance importance has increased in the last few decades and it has led to rise in awareness of adverse drug reaction reporting by both patients and health care professionals. Despite this, research shows reporting practice of health care professionals remains inadequate. Several educational and promotional activities were established in order to improve observed underreporting including the introduction of mobile applications that can be used to report adverse drug reactions. Objectives: We aimed to review literature on adverse drug reaction reporting applications and whether their introduction improved reporting practice in patients and health care professionals.Results: In this review, we have described several mobile application implementations in different countries. Moreover, we have illustrated some of the applications for particular patients, e.g. patients with multiple sclerosis. Conclusion: All of the included studies showed positive association between application use and ADR reporting. However, there is a great need for future high quality studies to confirm impact of mobile application on ADR reporting.

HEALTH-CARE PROFESSIONALS ; SAFETY INFORMATION ; PHARMACOVIGILANCE ; APP ; FEASIBILITY

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

168

2022.

104895

7

objavljeno

1386-5056

1872-8243

10.1016/j.ijmedinf.2022.104895

Povezanost rada

Kliničke medicinske znanosti

Poveznice
Indeksiranost